TARA
Protara Therapeutics
$2.49
+$0.02 (+0.81%)Oct 28, 2026
Key metrics
The numbers that frame TARA today
- Market cap
- $147.15M
- ROIC
- -46.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $2.28
- 52wk High
- $7.82
Growth
Revenue and earnings trend for TARA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TARA
Is Protara Therapeutics a good buy?
No. Protara Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Protara Therapeutics is selling at a very high price.
What is the market capitalization of TARA?
Protara Therapeutics's market capitalization is $147.15M.
What is the 52-week high for TARA stock?
The 52-week high for Protara Therapeutics is $7.82. The current close of $2.49 is 68.2% below that high.
What is the 52-week low for TARA stock?
The 52-week low for Protara Therapeutics is $2.28. The current close of $2.49 is 9.2% above that low.
Does TARA stock pay dividends?
Protara Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TARA?
Protara Therapeutics's Debt / Equity ratio is 0.02.